Simultaneous determination of first-line anti-tuberculosis drugs and one metabolite of isoniazid by liquid chromatography/tandem mass spectrometry in patients with human immunodeficiency virus-tuberculosis coinfectionYaru Xing, Lin Zhang, Yingying Li et al.|Heliyon|2021Cited by 15
Pharmacokinetic features of dolutegravir with rifampicin and rifabutin among patients coinfected with human immunodeficiency virus and tuberculosis/mycobacterium avium complexXiaoqin Le, Jun Chen, Xiaoye Guo et al.|International Journal of Infectious Diseases|2022Cited by 6
Simultaneously Determining Seven Second-Line Anti-TB Drugs by UHPLC-MS: Application for TDM in HIV-TB PatientsLin Yin, Yaru Xing, Xiaoqin Le et al.|Current Pharmaceutical Analysis|2021Cited by 1